Journals / Türk Kardiyoloji Derneği Arşivi / 2020 / Cilt: 48 - Sayı: 6

New indicator of cellular ischemia in coronary slow-flow phenomenon: Cell-free DNA

Koroner yavaş akım fenomeninde hücresel iskemi için yeni gösterge: Serbest DNA

Pages
558–565
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The plasma cfDNA level was 5.04±2.37 ng/µL inthe CSFP patients and 2.28±1.09 ng/µL in the NCA group(p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Coronary slow-flow phenomenon (CSFP) is defined as the delayed arrival of coronary blood flow to thedistal vascular bed in at least 1 major epicardial coronaryartery.
📊
Key Findings & Data:Cell-free DNA (cfDNA) is a type of DNA that circulates freely in the blood once released from nucleated cells.The aim of this study was to determine if the level of cfDNA,which is an indicator of ischemia at the cellular level, wasincreased in CSFP.Methods: The study included 46 patients in total: 23 patients with CSFP and 23 with a normal coronary angiogram(NCA).
💡
Conclusion & Impact:The plasma cfDNA level was 5.04±2.37 ng/µL inthe CSFP patients and 2.28±1.09 ng/µL in the NCA group(p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Coronary slow-flow phenomenon (CSFP) is defined as the delayed arrival of coronary blood flow to thedistal vascular bed in at least 1 major epicardial coronaryartery. Cell-free DNA (cfDNA) is a type of DNA that circulates freely in the blood once released from nucleated cells.The aim of this study was to determine if the level of cfDNA,which is an indicator of ischemia at the cellular level, wasincreased in CSFP.Methods: The study included 46 patients in total: 23 patients with CSFP and 23 with a normal coronary angiogram(NCA). The level of cfDNA, and clinical, biochemical, andangiographic features of the groups were compared.Results: The mean age was 53.8±10.3 years for the CSFPpatient group and 56.6±9.4 years for the NCA patient group.There was no statistically significant difference between thegroups in terms of basal clinical characteristics or laboratory data. The plasma cfDNA level was 5.04±2.37 ng/µL inthe CSFP patients and 2.28±1.09 ng/µL in the NCA group(p

Özet

Amaç: Koroner yavaş akım fenomeni (KYAF) en az bir majör epikardiyal koroner arterde kan akımının distal damar yatağına geç ulaşması olarak tanımlanır. Serbest hücresel DNA (shDNA), hücre nükleuslarından serbestleşen ve dolaşımda serbest olarak tespit edilebilen DNA tipidir. Bu çalışmada, KYAF’de hücresel düzeyde iskeminin göstergesi olan shDNA düzeylerinin artıp artmadığını göstermeyi amaçladık. Yöntemler: Bu çalışmaya, 23 KYAF’lı ve 23 anjiyografik olarak normal koroner arterlere (NKA) sahip toplam 46 hasta alındı. Grupların shDNA düzeyleri, klinik, biyokimyasal ve anjiyografik özellikleri karşılaştırıldı. Bulgular: Ortalama yaş KYAF grubunda 53.8±10.3 ve NKA grubunda 56.6±9.4 idi. Laboratuvar bulguları ve bazal klinik karekteristikleri yönünden gruplar arasında istatistiksel anlamlı fark yoktu. Plazma shDNA düzeyleri KYAF’da 5.04±2.37 ng/µL, NKA’da 2.28±1.09 ng/µL olarak tespit edildi (p

🔖

Cite This Article

HANCER, V. S., DOĞAN, A., YOLCU, M., KURTOĞLU, N., GÜRBÜZEL, M. (2022). New indicator of cellular ischemia in coronary slow-flow phenomenon: Cell-free DNA. Türk Kardiyoloji Derneği Arşivi, Cilt: 48 - Sayı: 6, 558–565. https://ajindex.com/articles/631995

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 1985;312:932–6
  2. Goel PK, Gupta SK, Agarwal A, Kapoor A. Slow coronary flow: a distinct angiographic subgroup in syndrome X. Angiology 2001;52:507–14
  3. Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon-a new coronary microvascular disorder. Cardiology 2002;97:197–202
  4. Saya S, Hennebry TA, Lozano P, Lazzara R, Schechter E. Coronary slow flow phenomenon and risk for sudden cardiac death due to ventricular arrhythmias: a case report and review of literature. Clin Cardiol 2008;31:352–5
  5. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries-a new angiographic finding. Am Heart J 1972;84:66– 71
  6. Cutri N, Zeitz C, Kucia AM, Beltrame JF. ST/T wave changes during acute coronary syndrome presentation in patients with the coronary slow flow phenomenon. Int J Cardiol 2011;146:457–8
  7. Horjeti B, Goda A. Acute ischemia manifestation in a patient with coronary slow flow phenomenon. J Electrocardiol 2012;45:277–9
  8. Marinescu MA, Löffler AI, Ouellette M, Smith L, Kramer CM, Bourque JM. Coronary microvascular dysfunction, microvascular angina, and treatment strategies. JACC Cardiovasc Imaging 2015;8:210–20
  9. Oktay V, Arat Özkan A. Coronary slow flow. Turk Kardiyol Dern Ars 2016;44:193–5
  10. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986;74:964–72
  11. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768–75
  12. Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000;46(3):319–23
  13. Song H, Nan Y, Cheng XW. Circulating cf-DNA: a promising, noninvasive tool for assessment of early cardiometabolic risk. Atherosclerosis 2014;233(1):307–9
  14. Mandel P, Metais P. Les acides nucléiques du plasma sanguin chez l’homme. [Article in French] C R Seances Soc Biol Fil 1948;142:241–3
  15. Pathak AK, Bhutani M, Kumar S, Mohan A, Guleria R. Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin Chem 2006;52:1833–42
  16. Bendich A, Wilczok T, Borenfreund E. Circulating DNA as